PharmaEssentia (TAI: 6446)

PharmaEssentia is a corporation based in Taipei, Taiwan. Established in 2003, the company is engaged in the research, development, production, and sale of therapeutic products for the treatment of human disease. It develops drugs to treat hepatitis, chronic myeloid leukemia, thrombocythemia (ET), myeloid fibrosis, polycythemia vera, hepatitis, and cancer. Geographically, it derives a majority of revenue from Taiwan. The assets are managed by the executive team.